These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35397747)

  • 1. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer.
    Mitsufuji S; Iwagami Y; Kobayashi S; Sasaki K; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Gotoh K; Takahashi H; Tanemura M; Doki Y; Eguchi H
    Ann Surg Oncol; 2022 Aug; 29(8):4937-4946. PubMed ID: 35397747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.
    Shimazaki R; Takano S; Satoh M; Takada M; Miyahara Y; Sasaki K; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Sogawa K; Motohashi S; Nomura F; Miyazaki M; Ohtsuka M
    Cell Oncol (Dordr); 2021 Aug; 44(4):937-950. PubMed ID: 34075561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.
    Amada K; Hijiya N; Ikarimoto S; Yanagihara K; Hanada T; Hidano S; Kurogi S; Tsukamoto Y; Nakada C; Kinoshita K; Hirashita Y; Uchida T; Shin T; Yada K; Hirashita T; Kobayashi T; Murakami K; Inomata M; Shirao K; Aoki M; Takekawa M; Moriyama M
    Cancer Sci; 2023 May; 114(5):2189-2202. PubMed ID: 36694355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.
    Yang S; Tang W; Azizian A; Gaedcke J; Ströbel P; Wang L; Cawley H; Ohara Y; Valenzuela P; Zhang L; Lal T; Sinha S; Rupin E; Hanna N; Ghadimi BM; Hussain SP
    Carcinogenesis; 2022 Dec; 43(12):1198-1210. PubMed ID: 36426859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.
    Hassan MK; Watari H; Han Y; Mitamura T; Hosaka M; Wang L; Tanaka S; Sakuragi N
    J Exp Clin Cancer Res; 2011 Dec; 30(1):113. PubMed ID: 22185350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Clusterin suppresses Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway.
    Zhang Y; Zhang Y; Xiao Y; Zhong C; Xiao F
    Ecotoxicol Environ Saf; 2019 Nov; 183():109465. PubMed ID: 31376806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
    Liu QH; Shi ML; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 11. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
    Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
    Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
    Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
    World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin Protects Lipotoxicity-Induced Apoptosis via Upregulation of Autophagy in Insulin-Secreting Cells.
    Hong SW; Lee J; Kim MJ; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):943-953. PubMed ID: 33261311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
    Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.
    Hassan MK; Watari H; Christenson L; Bettuzzi S; Sakuragi N
    Tumour Biol; 2011 Oct; 32(5):1031-47. PubMed ID: 21761117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.